Proteomics

Dataset Information

0

Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer

ABSTRACT: Aberrations in histone post-translational modifications (PTMs), as well as in the histone modifying enzymes (HMEs) that catalyze their deposition and removal, have been reported in many tumors, and many epigenetic inhibitors are currently under investigation for cancer treatment. Therefore, profiling epigenetic features in cancer could have important implications for the discovery of both biomarkers for patient stratification and novel epigenetic targets. In this study, we employed mass spectrometry based approaches to comprehensively profile histone H3 PTMs in a panel of normal and tumoral tissues for different cancer models

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Ovary, Breast

DISEASE(S): Head And Neck Cancer,Malignant Neoplasm Of Ovary,Breast Cancer

SUBMITTER: Roberta Noberini  

LAB HEAD: Tiziana Bonaldi

PROVIDER: PXD013311 | Pride | 2019-09-09

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
HNC1N.raw Raw
HNC1T.raw Raw
HNC2N.raw Raw
HNC3N.raw Raw
HNC4T.raw Raw
Items per page:
1 - 5 of 50
altmetric image

Publications

Aberrations in histone post-translational modifications (PTMs), as well as in the histone modifying enzymes (HMEs) that catalyze their deposition and removal, have been reported in many tumors and many epigenetic inhibitors are currently under investigation for cancer treatment. Therefore, profiling epigenetic features in cancer could have important implications for the discovery of both biomarkers for patient stratification and novel epigenetic targets. In this study, we employed mass spectrome  ...[more]

Similar Datasets

Proteomics Extensive and systematic rewiring of histone post-translational modifications in cancer model systems
2018-04-06 | PXD007235 | Pride
Proteomics Histone PTM profiling during the cell cycle
2019-09-09 | PXD013288 | Pride
Proteomics Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples
2015-10-14 | PXD002669 | Pride
Proteomics PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples
2017-07-17 | PXD006027 | Pride
Proteomics Comparison of in-gel digestion methods for histone PTM analysis
2021-09-09 | PXD024745 | Pride
Proteomics Alternative digestion approaches improve histone modification mapping by mass spectrometry in clinical samples
2010-10-08 | PXD009946 | Pride
Proteomics Histone PTMs profiles of maltonis treated cells
2023-02-13 | PXD031448 | Pride
Proteomics Histone post-translational modification analysis from low-abundance clinical samples
2021-09-09 | PXD024799 | Pride
Proteomics Epigenetic modifications associated with life cycle transitions in the brown alga Ectocarpus
2020-11-06 | PXD013535 | Pride
Proteomics Mass spectrometry-based profiling of histone posttranslational modifications in uveal melanoma tissue, human melanocytes, and uveal melanoma cell lines
2024-02-14 | PXD043551 | Pride